QCM
UTMD icon

Quantinno Capital Management’s Utah Medical Products UTMD Stock Holding History

Quantinno Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97M Buy
43,074
+13,233
+44% +$879K ﹤0.01% 1639
2026
Q1 		$1.85M Buy
29,841
+6,146
+26% +$387K ﹤0.01% 1674
2025
Q4 		$1.33M Buy
23,695
+739
+3% +$42.8K ﹤0.01% 1577
2025
Q3 		$1.45M Buy
22,956
+12,266
+115% +$726K ﹤0.01% 1329
2025
Q2 		$608K Buy
+10,690
New +$581K ﹤0.01% 1537

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quantinno Capital Management's UTMD Position: Q2 2026 in Review

Quantinno Capital Management increased its Utah Medical Products (UTMD) stake by 44% in Q2 2026, buying an estimated $879K and bringing the position to 43,074 shares worth $2.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1639.

Quantinno Capital Management first reported a position in UTMD in Q2 2025 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Quantinno Capital Management held 43,074 shares of Utah Medical Products worth $2.97M as of Q2 2026.
  • Quantinno Capital Management bought 13,233 Utah Medical Products shares in Q2 2026, an estimated $879K.
  • Utah Medical Products made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1639 holding.
  • Quantinno Capital Management first reported a position in Utah Medical Products in Q2 2025 and has held it in 5 quarters since.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.